Nevertheless, IgE specific targets remain currently unknown, although there may be cross-reactivity with environmental antigens, as patients with higher IgE levels and with allergic diseases were more likely to have onset in March, April, May, August, September, or October (21). This evidence concerns the gene IGHE and allergic disease.